Hoffman Michael B 4

What Happened

• Michael B. Hoffman, a director of Annovis Bio, made three open-market purchases on May 20, 2026, acquiring a total of 76,344 shares.
  • 2,562 shares at $1.75 each for $4,484
  • 18,849 shares at $1.80 each for $33,928
  • 54,933 shares at $1.90 each for $104,367
• These were purchases (code P), which are often viewed as a more informative signal than routine sales because they represent the insider adding to a position.

Key Details

• Transaction date: 2026-05-20; filing date: 2026-05-21 (timely filing).
• Prices and amounts: 2,562 @ $1.75; 18,849 @ $1.80; 54,933 @ $1.90.
• Total acquired: 76,344 shares for $142,779.
• Shares owned after the transaction: Not specified in the Form 4 filing.
• Footnote: The shares are held in a family trust formed by the reporting person; Hoffman has voting and investment power over those shares (Footnote F1).
• No 10b5-1 plan, gift, option exercise, or tax-withholding note was disclosed.

Context

• These were straightforward open-market purchases, not option exercises or gifts. Purchases by directors can be interpreted as the insider adding to exposure, but filings are factual records and do not state motives.
• For retail investors, note the purchase size and price levels relative to the company's recent trading to assess materiality; this filing reports modest dollar value (~$143k) overall.